Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Romania Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20121
20132
20142
20171
20211
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
H. Lundbeck A/S2
TauRx Therapeutics Ltd2
AB Science1
AstraZeneca1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease14
Dementia6
Brain Diseases3
Cognitive Dysfunction3
Neurodegenerative Diseases3
Memory Disorders2
Central Nervous System Diseases1
Cerebrovascular Disorders1
Cognition Disorders1
Frontotemporal Dementia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.